17 years of business development and fundraising experience in leading biotech companies.
Developed innovative large-scale translational programs with focus on immune modulators, anti-inflammatories and anti-diabetic therapeutics.
Identified and validated the role of novel therapeutic targets in diabetes and inflammatory bowel disease yielding over 15 patents.
Experience in bioinformatics, computational modeling, pre-clinical efficacy and safety studies (rats mouse and pig models) as well as human clinical trials.